Osimertinib (Tagrisso) and Ketamine Therapy | Tovani Health
Tagrisso (Osimertinib) — Third-generation EGFR TKI (EGFR-mutant non-small cell lung cancer)
Verdict at Tovani Health
Fully compatible with KAP; the EGFR-specific side effects are intrinsic.
Osimertinib and ketamine have no clinically significant direct interaction. Standard of care for EGFR-mutant NSCLC. CYP3A4 substrate (a osimertinib concern around strong inhibitors/inducers — affects osimertinib levels, not ketamine). The intrinsic class effects — rash, diarrhea, paronychia, and the more serious pneumonitis and QT prolongation — are EGFR TKI considerations independent of KAP.
If you take Tagrisso regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Tagrisso interacts with ketamine
Irreversible covalent inhibitor of EGFR with selectivity for activating and resistance T790M mutations. CYP3A4 substrate; weak BCRP inhibitor. No reciprocal effect on ketamine.
What we do at intake
Continue as prescribed. Disclose any concurrent CYP3A4 modulators — that's an osimertinib dose conversation independent of KAP.
Bottom line
Osimertinib and ketamine have no clinically significant direct interaction. Standard of care for EGFR-mutant NSCLC. CYP3A4 substrate (a osimertinib concern around strong inhibitors/inducers — affects osimertinib levels, not ketamine). The intrinsic class effects — rash, diarrhea, paronychia, and the more serious pneumonitis and QT prolongation — are EGFR TKI considerations independent of KAP.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Tagrisso (Osimertinib) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 23, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.